EW STOCK FORECAST: After giving 40% returns to investors over 1 year, will the mometum continue in 2022?

EW is trading 2.13% higher at $ 122.12 in the last trading session.

EW Stock Forecast: Momentum Summary

EW Stock Forecast: Performance Chart

EW Stock Forecast: Technical Analysis

EW Stock Forecast: Latest Videos

Edwards Lifesciences CEO on outlook for 2022: ‘We are just getting started’

EW Stock Forecast: Sentiment Analysis

Also Read: Moderna Stock Forecast

EW Stock Forecast: Latest News and Tweets

Ew Healthcare Partners Fund 2, Buys 5,050 Shares of TELA Bio, Inc. (NASDAQ:TELA) Stock

EW Stock Forecast: Company Background

Edward lifesciences is an American based medical technology company. It was founded in the year 1958 in Irvine, California. The company works on Artificial heart valves and hemodynamic monitoring and produces new technologies to treat late cardiovascular diseases. It was founded by an engineer Miles Lowell Edwards.

EW Stock Forecast: Q3 Results

• Sales increased 15% to 1.3 billion as of on 30^th September
• Increased 15% in TAVR sales
• Increased in US TAVR sales by 12% and OUS approximately 20%
• Full year 2021 sales guidance range changed
• EW reported that TAVR sales are $858 million in this third quarter of the financial year
• With 7% increase compared to third quarter of the last year surgical structural heart sales were $217 million
• The adjusted gross profit margin was 76.3% compared to 75.5% in the third quarter of last financial year.
• Research and development expenses were $238 million by an increase of 22%
• Free cash flow was $471 million and cash flow from operating activities is $532 million

-Rakesh Atla